Tofacitinib: efficiency and safety in long-term use

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studies2017 · 43 citations
2. 2Tofacitinib versus Methotrexate in Rheumatoid Arthritis2014 · 792 citations
3. 3Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis2016 · 79 citations
4. 4Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis2013 · 452 citations